This week: China’s additive manufacturing build-out and what it means for medicine, a France-licensed supply chain for 3D-printed drugs, an FDA call for new evidence pathways, a randomized trial for 3D-printed surgical simulators, two bioprinting papers, and the rest of the week in healthcare 3D printing.

The big thing

China is printing more of everything. Is that a problem?

Addireen’s new Ganzhou plant can build up to 50 metal printers a month. Eplus3D’s Beijing factory is sized for 300+ large metal systems a year. China exported 2.46 million consumer printers in four months, up 44.7%.

Medicine is following. China’s share of PubMed papers on 3D printing and bioprinting has climbed to 28% over the past decade, while the US share fell to 17%. China registered 199 printed devices by late 2024, ten times the 2020 count; the US had cleared 357+ by 2023. Chinese hospitals now publish bigger series, like a 224-patient anatomic cage study last month.

Is it all subsidy? Partly. Beijing has favored domestic machines and powders since 2018. But procurement lists do not sell millions of printers to consumers who can choose.

Intellectual property is the constant worry. A Texas jury awarded Stratasys about $27.6M against Bambu Lab, which will appeal. Millions of printers shipped while the case ran.

So is it a problem? Cheap hardware helps buyers. The risk is that the learning curve follows the volume. The West’s defensible layer is high-value applications, qualified workflows, outcomes data and talent. Tell us what you think. Read the full analysis.

Regulatory watch

• FDA seeks new regulatory science framework for innovative tech (Medical Design & Outsourcing, Sept 25). FDA’s device center wants input on evidence pathways for autonomous AI, generative AI and implants that grow with the patient. Comments close Nov 24 (docket FDA-2026-N-8563).
• MB Therapeutics cleared to manufacture cartridges for 3D printed drugs (3D ADEPT, Oct 1). France’s medicines regulator (ANSM) licensed a GMP site for drug cartridges that hospital-pharmacy printers turn into personalized doses. Printed drugs now have a regulated upstream supplier; Finland’s CurifyLabs runs a different model.
• Xenix Medical clears NanoACTIV surface for its Riva screws (Business Wire, Sept 30). A 510(k) extends a surface first cleared on Xenix’s printed titanium implants to machined screws. Not a printed-device clearance; we found no new 510(k) for an additively manufactured device this week.

Clinical & research

• Skill transfer from 3D-printed temporal bone training to cadaveric mastoidectomy: a randomized controlled trial (Otology & Neurotology). Thirty novice ENT residents in Sao Paulo. Two hours on a printed temporal bone raised blinded cadaver scores by 4.2 points. Small and single-center, but randomized evidence for printed simulators is rare.
• Airflow controlled droplet bioprinting enables high-throughput generation of iPSC-derived thymic organoids (Biofabrication). Pittsburgh swapped manual encapsulation for air-jet droplet printing: about 21,500 aggregates per mL, and functional T cells in mice. A manufacturing paper as much as a biology paper.
• 3D bioprinted human vascular organoid sheets promote functional ischemic repair (BMC Medicine). Tsinghua’s printed vessel sheets joined the host circulation and improved limb salvage in mice. Single-cell data show grafted cells remodel heavily after implantation.

Also this week

Business & manufacturing

• Healthcare growth reshapes 3D Systems’ $94.6M quarter (3D Printing Industry). Revenue was flat; healthcare grew 6.9% to $48.1M and is now about half of sales.
• Tenon Medical moves its 3D-printed SI joint screw to full launch (Ortho Spine News). The printed titanium lateral screw brought in about $1.2M during its alpha launch.
• Addireen opens Ganzhou facility for up to 50 metal AM systems a month (3D Printing Industry). Green-laser printers for pure copper parts such as AI-server cold plates.
• Carbon’s dual-cure patent survives appeal in Europe (TCT Magazine). Worth watching for resin suppliers selling into European dental labs.
• DiFusion to define a therapeutic biomaterials category at NASS 2026 (GlobeNewswire). Positioning for its ZFUZE spine material, which can be printed from filament. Company messaging, no new data.
• The speed paradox in 3D printing (Engineering.com). A Boston job shop says AI routing cut order-to-print time from four minutes to two or three.
• Meshy 7 review: how can humans keep up? (VoxelMatters). AI image-to-3D is good for concepts and decorative prints, not device-grade CAD.
• OSU adds in-situ sensing to a multi-head composite printer (3D Printing Industry). NSF-funded fiber-plus-polymer printing with machine-learning quality checks. No medical use yet.

Devices, materials & models

• Vital3D and Cleveland Clinic partner on patient-specific brain stents (NeuroNews International). A license to develop printed Y-stents for bifurcation aneurysms at about 1-micron resolution. Early stage.
• MIT and Johns Hopkins build a 3D-printed living cell collection device (VoxelMatters). Fluid shear lifts viable cells from tissue without enzymes, tested on fallopian tube samples.
• MIT develops bioresorbable batteries for ingestible devices (Medical Design & Outsourcing). A 1.84 V magnesium battery that dissolves; it powered stimulation for three days in animals. Not printed.
• 3D printing enables custom rubber gloves in smaller batches (Medical Xpress). Cranfield sprays and cures natural rubber in place, making small runs of fitted gloves viable.
• Building a beating heart: how 3D bioprinting is changing cardiac medicine (MD+DI). Minnesota’s Brenda Ogle: drug testing comes first; thickness and integration block therapy.
• ATCC wins $8.3M for organ-on-chip and organoid models (GlobeNewswire). NIAID and FDA contracts, a funding signal after FDA’s nonclinical-testing rule.

Community

• University of Nottingham brings 3D printing to hospital schools (TCT Magazine). Printers and training for 25 schools serving children with long hospital stays.

From 3DHEALS

• Episode #129: Medical 3D printing adoption in the EU with Naomi Nathan. The head of healthcare at Mobility Goes Additive on why hospital successes stall before system-wide adoption: reimbursement, evidence and Europe’s fragmented health systems.
• Next-Gen 3D Printed Orthotics and Prosthetics (Oct 15, virtual)

Get The Lattice Brief every week. Subscribe to The Lattice Brief